Improved healthy tissue sparing in proton therapy of lung tumors using statistically sound robust optimization and evaluation

•Worst-case robust planning does not provide quantified confidence levels.•Uncertainties were explicitly integrated during optimization/evaluation.•Target robustness on the edge of clinical acceptability was obtained.•Significant organ at risk sparing was achieved alongside adequate target robustness.